Medical devices, healthcare technology and the business of care
510(k) clearance · K261275

Unity Total Knee System, Unity Knee Cementless CR Femur

Corin, Ltd. · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK261275

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-17 for K261275, a traditional 510(k) submitted by Corin, Ltd. of Cirencester, GB, and received on 04/17/2026. The device is listed as the Unity Total Knee System, Unity Knee Cementless CR Femur, under regulation 888.3565 with classification product code MBH and subsequent product code JWH; the review panel and medical specialty are both orthopedic. SESE denotes clearance rather than PMA approval.

The record identifies the submission as a cementless, porous-coated, semi-constrained patello/femorotibial knee prosthesis, but the public fields do not specify which components, sizes or design changes distinguish this femur from prior Corin knee submissions, nor the predicate device relied upon. The page also notes the review was not conducted by a third party, was not a combination product, and had no authorized predetermined change control plan. No summary statement content, indications, or clinical performance data appear in the retrieved material, so the basis for the equivalence determination remains unknown from these fields.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261275
Regulatory pathway
510(k) premarket notification
Applicant
Corin, Ltd.
Product code
MBH
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer.

Applicant
Corin, Ltd.
Product code
MBH
FDA device class
2

FDA decision timeline

  1. K261275 received

    Application receipt date recorded by FDA.

  2. K261275 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MBH

Product / regulatory recordCompanyPathwayDecision dateSource
Smith & Nephew, Inc.510(k) clearanceSep 8, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Corin, Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cirencester

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records